Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
Aug 13, 2026, 10:31

Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials

Brad Wilson, Director of Medical Devices at Radcliffe Group US, shared a post on LinkedIn:

“The key trials at ESC 2026. Nicolas Van Mieghem and Philippe Bertrand unpacking what the data actually means.

Great insights looking beyond the headline results and into the questions that really matter:

  • Which patients benefit most?
  • When is the right time to intervene?
  • And how should the latest evidence influence the way we treat patients in practice?

A lot covered in 45 minutes and well worth a watch.

Trials discussed:

  • ACACIA-HCM: Aficamten in Non-obstructive HCM
  • STAREE: Statins for Healthy Ageing
  • AMUNDSEN: Early PCSK9 Inhibition After MI
  • LIBREXIA ACS: Can Factor XI Inhibition Change ACS Care?
  • PREMIUM: Is Aspirin-Free STEMI Treatment the Future?
  • A-CLOSE: Clopidogrel vs Extended DAPT After PCI
  • PVI-SHAM-AF: Does AF Ablation Outperform Placebo?
  • SINGLE-AF: Anticoagulation in Intermediate-Risk AF
  • LAACS-2: Surgical Left Atrial Appendage Closure
  • POPular ACE TAVI: Routine Protamine After TAVI
  • TAVI PCI: Revascularisation Before or After TAVI?
  • NOTION-4 and ACASA-TAVI: Does HALT Matter?
  • POET-II: Can Endocarditis Antibiotic Treatment Be Shortened?
  • PRAGUE 26: Catheter-Directed Therapy for Pulmonary Embolism
  • CMR GUIDE: Cardiac MRI-Guided ICD Selection
  • Syncope-Stopper: Should Some Syncope Patients Receive Early Pacing?
  • TRIC-I-HF: Can Tricuspid Intervention Improve Outcomes?”

Proceed to the video attached to the post.

Stay updated with Hemostasis Today.